TruScreen Group Limited (NZE:TRU)

Market Cap	11.10M
Revenue (ttm)	2.07M
Net Income (ttm)	-2.24M
Shares Out	554.91M
EPS (ttm)	-0.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	441,180
Average Volume	572,325
Open	0.0210
Previous Close	0.0200
Day's Range	0.0200 - 0.0210
52-Week Range	0.0150 - 0.0370
Beta	-0.22
RSI	35.84
Earnings Date	Jul 3, 2025

About TruScreen Group

TruScreen Group Limited, together with its subsidiaries, develops, manufacture, and sale of cancer detection devices and systems in Mexico, China, Russia, Vietnam, Zimbabwe, and the Middle East/North Africa. It offers the TruScreen cervical cancer screening device, a medical device for identifying and detecting the presence of precancerous and cancerous tissue on the cervix in real time. The company was formerly known as TruScreen Limited and changed its name to Truscreen Group Limited in August 2020. TruScreen Group Limited was incorporated in...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2013
• Country: New Zealand
• Stock Exchange: New Zealand Stock Exchange
• Ticker Symbol: TRU

Financial Performance

In 2024, TruScreen Group's revenue was 2.07 million, a decrease of -20.28% compared to the previous year's 2.60 million. Losses were -2.24 million, 9.41% more than in 2023.